We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+9.5%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$462M
AUM Growth
+$29.2M
Cap. Flow
-$6.33M
Cap. Flow %
-1.37%
Top 10 Hldgs %
31.14%
Holding
411
New
26
Increased
66
Reduced
79
Closed
11

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$1.63M
2
ADI icon
Analog Devices
ADI
+$1.26M
3
IBM icon
IBM
IBM
+$768K
4
IAU icon
iShares Gold Trust
IAU
+$507K
5
BLK icon
Blackrock
BLK
+$502K

Sector Composition

Rank Sector Weight
1 Technology 25.87%
2 Healthcare 13.61%
3 Financials 13.44%
4 Miscellaneous 13.22%
5 Consumer Staples 12.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAYX icon
26
Paychex
PAYX
$45.2B
$7.17M 1.55%
52,533
-189
-0.4% -$23.4K
NVS icon
27
Novartis
NVS
$292B
$4.81M 1.04%
54,960
-150
-0.3% -$12.5K
GOOG icon
28
Alphabet (Google) Class C
GOOG
$4.19T
$4.63M 1%
31,980
WY icon
29
Weyerhaeuser
WY
$17B
$4.62M 1%
112,229
-693
-0.6% -$26.3K
SYBT icon
30
Stock Yards Bancorp
SYBT
$2.48B
$4.57M 0.99%
71,571
+3
+0% +$189
HCI icon
31
HCI Group
HCI
$2.32B
$4.45M 0.96%
53,275
-1,350
-2% -$158K
MO icon
32
Altria Group
MO
$115B
$4.31M 0.93%
90,991
-389
-0.4% -$17.8K
EL icon
33
Estee Lauder
EL
$37.4B
$4.3M 0.93%
11,623
MKC icon
34
McCormick & Company Non-Voting
MKC
$14.9B
$4.25M 0.92%
43,995
-69
-0.2% -$5.88K
PM icon
35
Philip Morris
PM
$299B
$3.99M 0.86%
42,024
+209
+0.5% +$19.5K
ADP icon
36
Automatic Data Processing
ADP
$114B
$3.98M 0.86%
16,146
-15
-0.1% -$3.4K
RMD icon
37
ResMed
RMD
$34.7B
$3.95M 0.85%
15,158
-145
-0.9% -$37.6K
HIFS icon
38
Hingham Institution for Saving
HIFS
$650M
$3.87M 0.84%
9,212
EW icon
39
Edwards Lifesciences
EW
$52B
$3.58M 0.77%
27,632
-10
-0% -$1.17K
SYK icon
40
Stryker
SYK
$127B
$3.35M 0.72%
12,510
-445
-3% -$117K
TD icon
41
Toronto Dominion Bank
TD
$199B
$3.34M 0.72%
43,504
KO icon
42
Coca-Cola
KO
$386B
$3.2M 0.69%
54,014
-604
-1% -$33.6K
GILD icon
43
Gilead Sciences
GILD
$181B
$3.07M 0.67%
42,342
-699
-2% -$48.1K
OKTA icon
44
Okta
OKTA
$29.1B
$3.07M 0.66%
13,699
+561
+4% +$134K
ROP icon
45
Roper Technologies
ROP
$42.2B
$3.05M 0.66%
6,196
BRK.B icon
46
Berkshire Hathaway Class B
BRK.B
$1.08T
$2.95M 0.64%
9,860
SBCF icon
47
Seacoast Banking Corp of Florida
SBCF
$3.33B
$2.9M 0.63%
82,080
-1,094
-1% -$39.2K
NVO
48
Novo Nordisk
NVO
$202B
$2.77M 0.6%
49,376
-200
-0.4% -$10.8K
TFX icon
49
Teleflex
TFX
$5.92B
$2.56M 0.55%
7,780
-40
-0.5% -$13.6K
TRP icon
50
TC Energy
TRP
$64.4B
$2.39M 0.52%
51,325
-300
-0.6% -$14.8K

Similar funds

American Research & Management Company's Q4 2021 Portfolio in Review

As of Q4 2021, American Research & Management Company held 411 positions worth $462M, up 6.8% from $433M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

American Research & Management Company's Q4 2021 filing shows 26 new, 66 increased, 79 reduced and 11 closed positions. Its largest new stake was Kyndryl: 22,244 shares worth $403K. The largest sale was Adobe, an estimated $1.63M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • American Research & Management Company's largest Q4 2021 buy was Kyndryl: 22,244 shares worth $403K.
  • American Research & Management Company added most to Vanguard Morningstar Small-Cap Value ETF in Q4 2021, an estimated $209K increase.
  • American Research & Management Company's biggest Q4 2021 reduction was Adobe, cutting an estimated $1.63M.
  • American Research & Management Company fully exited PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q4 2021, selling an estimated $122K.
  • American Research & Management Company's ten largest holdings make up 31% of its $462M portfolio in Q4 2021.
  • American Research & Management Company opened 26 new positions and closed 11 in Q4 2021.
  • American Research & Management Company's portfolio value rose 6.8% quarter-over-quarter to $462M.

Based on American Research & Management Company's 13F filing for Q4 2021, filed 28 Jan 2022.